RBP1 and hepatocellular carcinoma: Recently, Liu et al. (2021) found that CRBP-1 is a crucial player in the initiation and progression of HCC, which provides an independent prognostic biomarker and therapeutic target for the diagnosis and treatment of HCC [79,80].